ROR1 in Endometrial Carcinoma: Correlation With Clinicopathological Features, Survival, and Prognosis

View Full Paper

Ask AI

Bookmark

High ROR1 expression significantly correlates with poor prognosis in endometrial carcinoma.
Immunohistochemistry analysis identified ROR1 expression in tumor tissues, influencing survival outcomes.
Kaplan–Meier models assessed overall survival differences based on ROR1 expression levels in patients.
Further studies are needed to validate ROR1 as a prognostic biomarker due to study limitations.

Discussion

No takes yet. Share an insight, caveat, or question.

Assessment of ROR1 expression predicts survival outcomes in endometrial carcinoma, highlighting its potential as a prognostic biomarker.

Zhang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark